Fig. 1From: Current views on the genetic landscape and management of variant acute promyelocytic leukemiaPML-RARA provided the therapeutic targets for ATRA and ATO in typical APL. B1 and 2: B box; CC: coiled-coil domain; DBD, DNA-binding domain; LBD, ligand binding domain; R: RING finger domainBack to article page